One fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable

Table 1 “High risk” group selection

	Non-selective NSAID users	COX-2 inhibitor users	Anti-platelet users
Past history of PUD	Y	Y	Y
Concurrent antiplatelet or anticoagulant therapy	Y	Y	Y
Concurrent corticosteroid therapy	Y
Age ≥ 60 yr	Y
Both: Age ≥ 60 yr and concurrent corticosteroids	Y		Y
High dose, duration > 2 wk	Y

Patients were considered as high risk according to guidelines [use of non-steroidal anti-inflammatory drug (NSAIDs), cyclooxygenase-2 (COX-2) inhibitor and/or anti-platelet agents in addition to features as listed in the first column; Y: High risk group; PUD: Peptic ulcer disease.